Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG

Guest: Amy Clouse, MD

STI screening can be done easily and regularly in the PCP office. Join Dr. Amy Clouse, Associate Director of the Family Medicine Residency Program at Abington-Jefferson Health, to learn how simple it can be to include STI screening in your typical patient visit, as well as how to overcome some of the troublesome barriers to screening that we face as clinicians.

Click here to learn more about other women's health programs in this special series.

This episode of Audio Abstracts reviews two studies conducted in Finland that investigated the link between premenopausal use of hormonal intrauterine treatment for menorrhagia and breast cancer incidence rates.

The first study, Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland, examined the incidence rates of several common cancers among intrauterine treatment users. The authors found that the risk of breast cancer increased within this patient population, while all other cancer risk profiles decreased.

As a follow-up to this study, a second publication titled Levonorgestrel-Releasing Intrauterine System and the Risk of Breast Cancer: A Nationwide Cohort Study, reported that patients using this IUD were at an increased risk of lobular and ductal breast cancers, specifically.

Host: Jennifer Caudle, DO

Guest: Tonya Chaffee, MD

The importance of STI screening is ever growing, as incidence of STIs reach a record high in the U.S. and untreated infections can have life-long consequences. On this program, Dr. Tonya Chaffee, Clinical Professor of Pediatrics at UCSF, will discuss the downstream effects of poor screening on patient outcomes and share ways to improve screening methods in practice. Click here to learn more about other women's health programs in this special series.

Host: Jennifer Caudle, DO

Guest: Caroline Mitchell, MD, MPH

Guest: Jeanne Marrazzo, MD, MPH

In the final installation of the "What's New in BV" series, Dr. Jennifer Caudle is joined by two leaders in the field to discuss a question that continues to puzzle healthcare professionals and their patients: Is bacterial vaginosis an STI?

Sexual transmission, impact of sexual partners, pathogens, and other STIs are just some of the points highlighted in this debate with Dr. Caroline Mitchell and Dr. Jeanne Marrazzo. Participate now and consider your own stance on the question!

What’s New in Bacterial Vaginosis, a non-certified educational series, is made possible by Lupin Pharmaceuticals, Inc. Content of the series is produced solely and controlled by ReachMD. This series is intended for healthcare professionals only.

NP-NP-0015

Host: Jennifer Caudle, DO

Guest: Caroline Mitchell, MD, MPH

Guest: Jeanne Marrazzo, MD, MPH

In the final installation of the "What's New in BV" series, Dr. Jennifer Caudle is joined by two leaders in the field to discuss a question that continues to puzzle healthcare professionals and their patients: Is bacterial vaginosis an STI?

Sexual transmission, impact of sexual partners, pathogens, and other STIs are just some of the points highlighted in this debate with Dr. Caroline Mitchell and Dr. Jeanne Marrazzo. Participate now and consider your own stance on the question!

What’s New in Bacterial Vaginosis, a non-certified educational series, is made possible by Lupin Pharmaceuticals, Inc. Content of the series is produced solely and controlled by ReachMD. This series is intended for healthcare professionals only.

NP-NP-0015

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG

Guest: Burton S. Brodsky, MD, FACOG

Low awareness of women’s risk factors and symptoms for ovarian cancer, compounded by common use of diagnostic laboratory tests that are less sensitive and not specifically approved for assessing the risk of malignant adnexal mass, are the most important reasons that the great majority of women with ovarian cancer are only diagnosed in late stage disease, when prognosis is far worse.

In this CME activity, join Dr. Burton Brodsky as he reviews best practices in malignancy risk assessment of adnexal mass to improve the detection of ovarian cancer in pre and postmenopausal women in earlier stages, ultimately enhancing their chances at surviving this devastating condition. Additionally, we will share practical strategies to best inform and empower patients, as well as practice management implications to facilitate patients and clinicians’ access to guideline recommended tools for ovarian cancer risk stratification.

Host: Amy Mackey, MD

Guest: Kahlil Demonbreun, DNP, FAANP

Rates of sexually transmitted infections (STIs) among our adolescent and young adult population are at an all-time high. Join Dr. Kahlil Demonbreun to discuss the value of universal screening, and how its implementation positively impacts women’s health outcomes. You might pick up some excellent tips on how to approach these difficult conversations with your patients! Click here to learn more about other women's health programs in this special series.

Host: Jennifer Caudle, DO

Guest: Paul Nyirjesy, MD

Guest: Katharine Smith, NP

Joining host Dr. Jennifer Caudle is Dr. Paul Nyirjesy, Professor of Obstetrics and Gynecology and Medicine at Drexel University College of Medicine, and Director of the Drexel Vaginitis Center, alongside Katharine Smith, Nurse Practitioner at the Drexel Vaginitis Center at Drexel University. Together, they discuss the common yet troublesome diagnosis and management of bacterial vaginosis.

What’s New in Bacterial Vaginosis, a non-certified educational series, is made possible by Lupin Pharmaceuticals, Inc. Content of the series is produced solely and controlled by ReachMD. This series is intended for healthcare professionals only.

NP-NP-0011

Host: Jennifer Caudle, DO

Guest: Paul Nyirjesy, MD

Guest: Katharine Smith, NP

Joining host Dr. Jennifer Caudle is Dr. Paul Nyirjesy, Professor of Obstetrics and Gynecology and Medicine at Drexel University College of Medicine, and Director of the Drexel Vaginitis Center, alongside Katharine Smith, Nurse Practitioner at the Drexel Vaginitis Center at Drexel University. Together, they discuss the common yet troublesome diagnosis and management of bacterial vaginosis.

What’s New in Bacterial Vaginosis, a non-certified educational series, is made possible by Lupin Pharmaceuticals, Inc. Content of the series is produced solely and controlled by ReachMD. This series is intended for healthcare professionals only.

NP-NP-0011

Host: Amy Mackey, MD

Guest: Mark Spitzer, MD

Prior to 2012 there were competing cervical cancer screening guidelines from the American Cancer Society and the United States Preventive Services Task Force (the USPSTF), leading providers to follow their own dictates when screening patients. In this edition of Advances in Women’s Health, host Dr. Amy Mackey is joined by Dr. Mark Spitzer with the Center for Colposcopy in New Hyde Park, Long Island, New York to discuss cervical cancer screening updates, including the current consensus guidelines, the interim guidance on HPV primary screening, and the latest data on cytology and co-testing. Click here to learn more about other women's health programs in this special series.